Bellmore, NY, United States of America

Robert D Kross

This inventor holds 41 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents, primarily in Topical Formulations. Top assignees: Alcide Corporation, Hydro Optics, Inc., Kantian Sciences Corporation. Active years: 1976-2022.

USPTO Granted Patents = 41 

% Patents Active = 85.4

 

Average Co-Inventor Count = 1.3

ph-index = 18

Forward Citations = 871(Granted Patents)


Location History:

  • Bellemore, NY (US) (1991 - 1993)
  • Bellmore, NY (US) (1976 - 2022)

Company Filing History:


Years Active: 1976-2022

Loading Chart...
Loading Chart...
Areas of Expertise:
Topical Formulations
Disinfection Methods
Antimicrobial Composition
Acne Treatment
Hyperglycemia Treatment
Oral Rinse
Skin Conditions
Hydrogel Composition
Wound Repair
Inflammatory Diseases
Chlorine Dioxide
41 patents (USPTO):Explore Patents

Title:

Inventor Spotlight: Robert D Kross

Introduction:

Robert D Kross, a talented inventor hailing from Bellmore, NY, has made significant contributions to the world of innovation with his groundbreaking ideas and inventions.

Latest Patents:

Robert D Kross holds several patents in various fields, showcasing his diverse range of expertise and creativity. His latest patents include cutting-edge technologies in the fields of electronics, robotics, and sustainable energy solutions.

Career Highlights:

Throughout his illustrious career, Robert D Kross has consistently pushed the boundaries of what is possible, earning a reputation as a visionary inventor. His innovative spirit and dedication to excellence have led to the successful development of numerous groundbreaking inventions that have had a lasting impact on society.

Collaborations:

Robert D Kross has collaborated with leading experts and organizations in the industry, leveraging his unique skill set to drive innovation forward. His ability to work effectively in multidisciplinary teams has resulted in the

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…